| UniProt ID | TXLNG_HUMAN | |
|---|---|---|
| UniProt AC | Q9NUQ3 | |
| Protein Name | Gamma-taxilin | |
| Gene Name | TXLNG | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 528 | |
| Subcellular Localization | Nucleus membrane . Cytoplasm, cytosol . | |
| Protein Description | May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression.. | |
| Protein Sequence | MATRVEEAARGRGGGAEEATEAGRGGRRRSPRQKFEIGTMEEAGICGLGVKADMLCNSQSNDILQHQGSNCGGTSNKHSLEEDEGSDFITENRNLVSPAYCTQESREEIPGGEARTDPPDGQQDSECNRNKEKTLGKEVLLLMQALNTLSTPEEKLAALCKKYADLLEESRSVQKQMKILQKKQAQIVKEKVHLQSEHSKAILARSKLESLCRELQRHNKTLKEENMQQAREEEERRKEATAHFQITLNEIQAQLEQHDIHNAKLRQENIELGEKLKKLIEQYALREEHIDKVFKHKELQQQLVDAKLQQTTQLIKEADEKHQREREFLLKEATESRHKYEQMKQQEVQLKQQLSLYMDKFEEFQTTMAKSNELFTTFRQEMEKMTKKIKKLEKETIIWRTKWENNNKALLQMAEEKTVRDKEYKALQIKLERLEKLCRALQTERNELNEKVEVLKEQVSIKAAIKAANRDLATPVMQPCTALDSHKELNTSSKRALGAHLEAEPKSQRSAVQKPPSTGSAPAIESVD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Methylation | TRVEEAARGRGGGAE CHHHHHHCCCCCCHH | 42.25 | 115368707 | |
| 12 | Methylation | VEEAARGRGGGAEEA HHHHHCCCCCCHHHH | 34.72 | 24129315 | |
| 24 | Methylation | EEATEAGRGGRRRSP HHHHHCCCCCCCCCH | 51.98 | 24129315 | |
| 27 | Methylation | TEAGRGGRRRSPRQK HHCCCCCCCCCHHHC | 33.39 | 30989833 | |
| 30 | Phosphorylation | GRGGRRRSPRQKFEI CCCCCCCCHHHCEEC | 23.71 | 22817900 | |
| 43 | Ubiquitination | EIGTMEEAGICGLGV ECCCHHHHCCCCCCC | 10.19 | 32015554 | |
| 54 | Sulfoxidation | GLGVKADMLCNSQSN CCCCCHHHHCCCCCC | 5.70 | 21406390 | |
| 58 | Phosphorylation | KADMLCNSQSNDILQ CHHHHCCCCCCCHHH | 33.71 | 23663014 | |
| 60 | Phosphorylation | DMLCNSQSNDILQHQ HHHCCCCCCCHHHHC | 35.97 | 23663014 | |
| 69 | Phosphorylation | DILQHQGSNCGGTSN CHHHHCCCCCCCCCC | 23.52 | 29978859 | |
| 70 | Ubiquitination | ILQHQGSNCGGTSNK HHHHCCCCCCCCCCC | 34.96 | 21890473 | |
| 72 | Ubiquitination | QHQGSNCGGTSNKHS HHCCCCCCCCCCCCC | 46.81 | 22817900 | |
| 73 | Ubiquitination | HQGSNCGGTSNKHSL HCCCCCCCCCCCCCC | 28.33 | 22817900 | |
| 74 | Phosphorylation | QGSNCGGTSNKHSLE CCCCCCCCCCCCCCC | 17.89 | 26714015 | |
| 75 | Ubiquitination | GSNCGGTSNKHSLEE CCCCCCCCCCCCCCC | 47.35 | 32015554 | |
| 75 | Phosphorylation | GSNCGGTSNKHSLEE CCCCCCCCCCCCCCC | 47.35 | 27251275 | |
| 79 | Phosphorylation | GGTSNKHSLEEDEGS CCCCCCCCCCCCCCC | 38.80 | 30576142 | |
| 86 | Phosphorylation | SLEEDEGSDFITENR CCCCCCCCCCCCCCC | 27.57 | 25159151 | |
| 88 | Ubiquitination | EEDEGSDFITENRNL CCCCCCCCCCCCCCC | 8.79 | 24816145 | |
| 90 | Phosphorylation | DEGSDFITENRNLVS CCCCCCCCCCCCCCC | 27.48 | 29978859 | |
| 97 | Phosphorylation | TENRNLVSPAYCTQE CCCCCCCCCCCCCHH | 13.64 | 19664994 | |
| 100 | Phosphorylation | RNLVSPAYCTQESRE CCCCCCCCCCHHHHC | 10.22 | 23927012 | |
| 102 | Phosphorylation | LVSPAYCTQESREEI CCCCCCCCHHHHCCC | 23.77 | 22167270 | |
| 105 | Phosphorylation | PAYCTQESREEIPGG CCCCCHHHHCCCCCC | 34.86 | 23927012 | |
| 116 | Phosphorylation | IPGGEARTDPPDGQQ CCCCCCCCCCCCCCC | 60.96 | 26074081 | |
| 126 | Ubiquitination | PDGQQDSECNRNKEK CCCCCCCCCCHHHCH | 44.06 | 24816145 | |
| 134 | Phosphorylation | CNRNKEKTLGKEVLL CCHHHCHHHHHHHHH | 41.66 | - | |
| 143 | Ubiquitination | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 33845483 | |
| 143 | Ubiquitination | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 21890473 | |
| 143 | Neddylation | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 32015554 | |
| 145 | Ubiquitination | EVLLLMQALNTLSTP HHHHHHHHHHCCCCH | 6.71 | 22817900 | |
| 146 | Ubiquitination | VLLLMQALNTLSTPE HHHHHHHHHCCCCHH | 2.57 | 22817900 | |
| 161 | Ubiquitination | EKLAALCKKYADLLE HHHHHHHHHHHHHHH | 50.06 | 32015554 | |
| 162 | Acetylation | KLAALCKKYADLLEE HHHHHHHHHHHHHHH | 44.68 | 26051181 | |
| 163 | Phosphorylation | LAALCKKYADLLEES HHHHHHHHHHHHHHH | 7.28 | 20068231 | |
| 170 | Phosphorylation | YADLLEESRSVQKQM HHHHHHHHHHHHHHH | 22.08 | 20068231 | |
| 172 | Phosphorylation | DLLEESRSVQKQMKI HHHHHHHHHHHHHHH | 37.87 | 28509920 | |
| 175 | Ubiquitination | EESRSVQKQMKILQK HHHHHHHHHHHHHHH | 50.64 | 29967540 | |
| 199 | Ubiquitination | VHLQSEHSKAILARS HHCCCHHHHHHHHHH | 21.52 | 24816145 | |
| 207 | Ubiquitination | KAILARSKLESLCRE HHHHHHHHHHHHHHH | 51.20 | 32015554 | |
| 210 | Phosphorylation | LARSKLESLCRELQR HHHHHHHHHHHHHHH | 43.11 | 24719451 | |
| 220 | Ubiquitination | RELQRHNKTLKEENM HHHHHHHHHHHHHHH | 49.46 | 24816145 | |
| 223 | Acetylation | QRHNKTLKEENMQQA HHHHHHHHHHHHHHH | 69.11 | 26051181 | |
| 238 | Ubiquitination | REEEERRKEATAHFQ HHHHHHHHHHHHHHH | 58.90 | 32015554 | |
| 275 | Neddylation | ENIELGEKLKKLIEQ HHHHHHHHHHHHHHH | 64.90 | 32015554 | |
| 275 | Ubiquitination | ENIELGEKLKKLIEQ HHHHHHHHHHHHHHH | 64.90 | 22817900 | |
| 277 | Ubiquitination | IELGEKLKKLIEQYA HHHHHHHHHHHHHHH | 57.51 | 22817900 | |
| 278 | Ubiquitination | ELGEKLKKLIEQYAL HHHHHHHHHHHHHHH | 66.20 | 22817900 | |
| 283 | Phosphorylation | LKKLIEQYALREEHI HHHHHHHHHHHHHHH | 8.53 | 20068231 | |
| 292 | Acetylation | LREEHIDKVFKHKEL HHHHHHHHHHCCHHH | 49.30 | 26051181 | |
| 292 | Ubiquitination | LREEHIDKVFKHKEL HHHHHHHHHHCCHHH | 49.30 | - | |
| 301 | Ubiquitination | FKHKELQQQLVDAKL HCCHHHHHHHHHHHH | 51.72 | 24816145 | |
| 307 | Ubiquitination | QQQLVDAKLQQTTQL HHHHHHHHHHHHHHH | 42.22 | 29967540 | |
| 309 | Ubiquitination | QLVDAKLQQTTQLIK HHHHHHHHHHHHHHH | 37.56 | 24816145 | |
| 319 | Ubiquitination | TQLIKEADEKHQRER HHHHHHHHHHHHHHH | 67.57 | 29967540 | |
| 331 | Ubiquitination | REREFLLKEATESRH HHHHHHHHHHHHHHH | 47.66 | 24816145 | |
| 370 | Ubiquitination | EFQTTMAKSNELFTT HHHHHHHHHCHHHHH | 42.88 | 32015554 | |
| 371 | Phosphorylation | FQTTMAKSNELFTTF HHHHHHHHCHHHHHH | 26.46 | 20068231 | |
| 374 | Ubiquitination | TMAKSNELFTTFRQE HHHHHCHHHHHHHHH | 5.59 | 24816145 | |
| 376 | Phosphorylation | AKSNELFTTFRQEME HHHCHHHHHHHHHHH | 37.33 | 20068231 | |
| 377 | Phosphorylation | KSNELFTTFRQEMEK HHCHHHHHHHHHHHH | 14.97 | 20068231 | |
| 382 | Ubiquitination | FTTFRQEMEKMTKKI HHHHHHHHHHHHHHH | 4.55 | 24816145 | |
| 386 | Phosphorylation | RQEMEKMTKKIKKLE HHHHHHHHHHHHHHH | 40.01 | 17081983 | |
| 388 | Acetylation | EMEKMTKKIKKLEKE HHHHHHHHHHHHHHH | 51.06 | 12436935 | |
| 402 | Acetylation | ETIIWRTKWENNNKA HHHHEEECCCCCHHH | 43.89 | 25953088 | |
| 430 | Acetylation | EYKALQIKLERLEKL HHHHHHHHHHHHHHH | 31.19 | 26051181 | |
| 451 | Ubiquitination | ERNELNEKVEVLKEQ HHHHHHHHHHHHHHH | 42.49 | 29967540 | |
| 460 | Phosphorylation | EVLKEQVSIKAAIKA HHHHHHHHHHHHHHH | 20.33 | 21406692 | |
| 474 | Phosphorylation | AANRDLATPVMQPCT HHCCCCCCCCCCCCC | 24.58 | 26462736 | |
| 481 | Phosphorylation | TPVMQPCTALDSHKE CCCCCCCCHHHHHCC | 36.62 | - | |
| 487 | Acetylation | CTALDSHKELNTSSK CCHHHHHCCCCCHHH | 68.78 | 26051181 | |
| 491 | Phosphorylation | DSHKELNTSSKRALG HHHCCCCCHHHHHHH | 47.18 | 29214152 | |
| 506 | Ubiquitination | AHLEAEPKSQRSAVQ HHHCCCCHHHHHCCC | 51.21 | 24816145 | |
| 510 | Phosphorylation | AEPKSQRSAVQKPPS CCCHHHHHCCCCCCC | 25.75 | 29396449 | |
| 514 | Ubiquitination | SQRSAVQKPPSTGSA HHHHCCCCCCCCCCC | 52.90 | 24816145 | |
| 514 | Acetylation | SQRSAVQKPPSTGSA HHHHCCCCCCCCCCC | 52.90 | 30593163 | |
| 517 | Phosphorylation | SAVQKPPSTGSAPAI HCCCCCCCCCCCCCC | 54.66 | 25159151 | |
| 518 | Phosphorylation | AVQKPPSTGSAPAIE CCCCCCCCCCCCCCC | 40.71 | 25159151 | |
| 520 | Phosphorylation | QKPPSTGSAPAIESV CCCCCCCCCCCCCCC | 31.03 | 25159151 | |
| 526 | Phosphorylation | GSAPAIESVD----- CCCCCCCCCC----- | 26.02 | 30108239 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TXLNG_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TXLNG_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TXLNG_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TBK1_HUMAN | TBK1 | physical | 21903422 | |
| TXLNA_HUMAN | TXLNA | physical | 21903422 | |
| TXLNB_HUMAN | TXLNB | physical | 21903422 | |
| WIPF2_HUMAN | WIPF2 | physical | 22939629 | |
| UBP3_HUMAN | USP3 | physical | 22939629 | |
| CHAP1_HUMAN | CHAMP1 | physical | 22939629 | |
| ZC11A_HUMAN | ZC3H11A | physical | 22939629 | |
| UBA1_HUMAN | UBA1 | physical | 22939629 | |
| CDV3_HUMAN | CDV3 | physical | 26344197 | |
| DDX17_HUMAN | DDX17 | physical | 26344197 | |
| TXLNA_HUMAN | TXLNA | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-517, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-105, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-386, AND MASSSPECTROMETRY. | |